[Surgery of peptic ulcer 10 years after the introduction of anti-H2 agents]. 1988

M Bartolotta, and A Carditello
Istituto di Discipline Chirurgiche Generali e Speciali Université de Messine, Italie.

To evaluate the actual rate of both elective and emergency surgical operations for peptic ulcer, a questionnaire on the incidence of these operations was sent to 60 european departments of digestive surgery. 28 centers entered the trial, with the following results: 1,800 patients operated on; marked decrease of elective operations (100 percent of the centers); High decrease of emergency operations for hemorrhagic ulcer (80 percent of the centers). Decrease of emergency operations for perforation (50 percent of the centers). Decrease of operations for stenosis (70 percent of the centers). No-responders ulcers (ever more rare) and acute complications of patients with acute ulcer (elderly patients, under steroid or chemotherapy or intensive care) represent the resting indications to surgery. These results confirm the decline of surgery ten years after the introduction of H2 receptor antagonists.

UI MeSH Term Description Entries
D010437 Peptic Ulcer Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS). Gastroduodenal Ulcer,Marginal Ulcer,Gastroduodenal Ulcers,Marginal Ulcers,Peptic Ulcers,Ulcer, Gastroduodenal,Ulcer, Marginal,Ulcer, Peptic,Ulcers, Gastroduodenal,Ulcers, Marginal,Ulcers, Peptic
D006635 Histamine H2 Antagonists Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. Antihistaminics, H2,H2 Receptor Blockader,Histamine H2 Antagonist,Histamine H2 Blocker,Histamine H2 Receptor Antagonist,Histamine H2 Receptor Antagonists,Histamine H2 Receptor Blockader,Histamine H2 Receptor Blockaders,Antagonists, Histamine H2,Blockaders, Histamine H2 Receptor,H2 Receptor Blockaders,Histamine H2 Blockers,Receptor Antagonists, Histamine H2,Receptor Blockaders, H2,Antagonist, Histamine H2,Blockader, H2 Receptor,Blockaders, H2 Receptor,Blocker, Histamine H2,Blockers, Histamine H2,H2 Antagonist, Histamine,H2 Antagonists, Histamine,H2 Antihistaminics,H2 Blocker, Histamine,H2 Blockers, Histamine,Receptor Blockader, H2
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer

Related Publications

M Bartolotta, and A Carditello
October 1987, Minerva chirurgica,
M Bartolotta, and A Carditello
December 1985, Revista espanola de las enfermedades del aparato digestivo,
M Bartolotta, and A Carditello
April 1992, Hepato-gastroenterology,
M Bartolotta, and A Carditello
July 1987, The American surgeon,
M Bartolotta, and A Carditello
July 1984, Deutsche medizinische Wochenschrift (1946),
M Bartolotta, and A Carditello
September 1992, Nihon Geka Gakkai zasshi,
M Bartolotta, and A Carditello
March 1984, American journal of surgery,
M Bartolotta, and A Carditello
April 1972, The American surgeon,
M Bartolotta, and A Carditello
January 1985, Revista chilena de pediatria,
Copied contents to your clipboard!